THE EFFECT OF RELATIVE HUMIDITY ON THE MICROBIAL BARRIER PROPERTIES OF POROUS PACKAGING MATERIALS USED IN THE MEDICAL DEVICE INDUSTRY by Blocher, Jennifer
Clemson University
TigerPrints
All Theses Theses
8-2009
THE EFFECT OF RELATIVE HUMIDITY ON
THE MICROBIAL BARRIER PROPERTIES OF
POROUS PACKAGING MATERIALS USED IN
THE MEDICAL DEVICE INDUSTRY
Jennifer Blocher
Clemson University, jen.blocher@gmail.com
Follow this and additional works at: https://tigerprints.clemson.edu/all_theses
Part of the Engineering Commons
This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized
administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.
Recommended Citation
Blocher, Jennifer, "THE EFFECT OF RELATIVE HUMIDITY ON THE MICROBIAL BARRIER PROPERTIES OF POROUS
PACKAGING MATERIALS USED IN THE MEDICAL DEVICE INDUSTRY" (2009). All Theses. 641.
https://tigerprints.clemson.edu/all_theses/641
 
 
 
 
 
 
 
 
TITLE PAGE 
THE EFFECT OF RELATIVE HUMIDITY ON THE 
MICROBIAL BARRIER PROPERTIES OF POROUS 
PACKAGING MATERIALS USED IN THE MEDICAL DEVICE 
INDUSTRY 
 
 
A Thesis 
Presented to 
the Graduate School of  
Clemson University 
 
 
In Partial Fulfillment 
of the Requirements for the Degree 
Master of Science 
Packaging Science 
 
 
by 
Jennifer Blocher 
August 2009 
 
 
Accepted by: 
Dr. Duncan O. Darby, Committee Chair 
Dr. Kay Cooksey 
Dr. Laura Bix 
ABSTRACT 
 
 
Porous packaging materials, such as medical-grade paper and Tyvek®, are used 
often by the medical device industry for packaging sterile devices when the 
products are sterilized post packaging.  Their use can be attributed to the fact 
that multiple sterilization methods require the ability for vapors to enter and/or 
exit the package efficiently, while simultaneously reducing the amount of 
microbes entering the package.  Much research as been done to study the 
effects of multiple material and environmental factors, such as material structure 
and dispersion concentration, on the microbial barrier properties of these 
materials, however no research had been conducted to examine the impact of 
relative humidity.  This research was aimed at identifying the effect relative 
humidity levels can have on the microbial barriers of four porous packaging 
materials: coated and uncoated Tyvek® 1073B, dot coated Ovantex®, and 
coated medical-grade paper.  Research was conducted with slight adjustments to 
the ASTM F2638-07 test standard method for using aerosol filtration for 
measuring the performance of porous packaging materials as a surrogate 
microbial barrier.  The adjustments included preconditioning samples at 15%, 
50%, and 90% relative humidity levels and switching samples after each tested 
flow rate.  Results from testing show that the microbial barrier properties of 
medical-grade paper were significantly impacted by fluctuations in relative 
humidity.  Microbial barrier properties of the medical-grade paper and Ovantex® 
were also significantly impacted by the dispersion flow rate through the material 
sample, while uncoated Tyvek® 1073B was found to only be slightly impacted.  
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Interestingly, when analyzing the coated and uncoated Tyvek®, a data analysis 
suggests that the addition of the heat seal coating may significantly decrease the 
impact flow rate has on microbial penetration. 
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INTRODUCTION 
 
In 2002, a “Surgical and Medical Equipment” marketing survey valued the 
medical device industry at $140 billion and rapidly growing (“Surgical and 
Medical Equipment,” 2009).  Manufacturers produce a wide variety of products 
ranging from diagnostic equipment and x-ray machines to therapeutic devices 
and cardiac catheters.   
The sterility of most medical device products is of paramount importance.  
Companies are expected to design a packaging system that will protect their 
product from manufacture, through distribution channels, to point of use.   
Terminally sterile devices, products sterilized while inside a sealed package, also 
require consideration of the sterilization method and in some cases must be 
designed to facilitate the sterilization process.   
Several techniques can be used to sterilize medical products.  Each 
sterilization method adds different constraints, requirements, and stresses to the 
packaging system.  Because some sterilization methods such as Ethylene Oxide 
(EtO), Vaporized Hydrogen Peroxide (VHP), and steam autoclave use gases or 
vapors to achieve sterility, porous materials, such as medical grade papers and 
Tyvek®, have become the prominent packaging materials in the medical device 
industry.  Porous materials allow gases and vapors to enter and exit the package 
while simultaneously inhibiting microbes from entering the package.  There are 
several theories as to how the reduction of microbial ingress is achieved within 
porous materials.  Many suggest the causes for reduction are attributed to 
materials acting as a depth filter or creating a tortuous path that traps microbes 
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as the air weaves through the material (DuPont,19) (Permeability, 65).  With 
porous materials playing such a large and important role in medical device 
packaging, it is important that the industry fully understands the microbial barrier 
properties of these materials and how they are affected throughout the 
distribution cycle.  
Currently, most data on the microbial penetration levels of these materials 
have been determined using ASTM F1608-00: Standard Test for Microbial 
Ranking of Porous Packaging Materials (Exposure Chamber Method).  In this 
test method, Section 8- Sample Preparation states that the test can be performed 
on materials “before or after they are subjected to other conditions such as heat 
or cold, relative humidity, different sterilization processes, real time, or 
accelerated aging.”  Although preconditioning is permissible following the current 
ASTM methods, there is limited information available that discusses the effects of 
relative humidity levels on the microbial barrier properties of materials typically 
employed to package terminally sterile medical devices.  Since significant 
changes to relative humidity levels during the packaging distribution cycle occur, 
it is important to research how relative humidity levels affect the microbial 
penetration levels and potentially the sterility of medical device products. 
This research analyzes the microbial barrier performance of porous 
packaging materials conditioned under controlled atmospheric conditions.  It was 
designed to assist in forming a baseline understanding of how relative humidity 
affects microbial barrier properties of the tested porous materials.   
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To ensure that the optimum penetration flow rate for each material was 
tested, research testing was conducted using ASTM F2638-07: Standard Test 
Method for Using Aerosol Filtration for Measuring the Performance of Porous 
Packaging Materials as a Surrogate Microbial Barrier as a guideline with slight 
variations to sample preparation.  Unlike the ASTM F1608-00 standard, the 
ASTM F2638-07 standard varies the challenge flow rates in order to test the 
sample at the optimum flow rate for microbial penetration through the sample.  
Four different medical grade porous packaging materials were subjected to 
testing:  Tyvek® 1073B, coated Tyvek® 1073B, dot coated Ovantex®, and 
coated 55 pound medical-grade paper.  Materials were preconditioned and 
tested with slight modifications to the ASTM F2638-07 test method.  All data was 
then studied to determine if there was any correlation between the relative 
humidity levels, flow rates, and the microbial barrier properties for each of the 
four materials tested.   
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 REVIEW OF LITERATURE 
 
Medical Devices  
When researching medical device packaging, it is important to first 
understand what constitutes a medical device.  Defining a medical device can be 
complicated when one considers that different countries define devices 
differently.  For this reason, the International Standards Organization (ISO) has 
defined a medical device as  
“any instrument, apparatus, implement, machine, appliance, implant, in vitro 
reagent or calibrator, software, material or other related article, intended by the 
manufacturer to be used, alone or in combination, for human beings for one or 
more of the specific purpose(s) of  
• Diagnosis, prevention, monitoring, treatment or alleviation of disease 
• Diagnosis, monitoring, treatment, alleviation of or compensation for an 
injury 
• Investigation, replacement, modification or support of the anatomy or of a 
physiological process 
• Supporting or sustaining life 
• Control of conception 
• Disinfection of medical devices 
• Providing information for medical purposes by means of in vitro 
examination of specimens derived from the human body 
 
And which does not achieve its primary intended action in or on the human body 
by pharmacological, immunological or metabolic means, but which may be 
assisted in its function by such means (ISO 11607-1, 2).”  
Under this definition, medical devices encompass a large range of 
products.  “Complicated capital equipment, such as MRI tunnels and x-ray 
machines are medical devices, but so are simple, commodity-like items 
 11
such as tongue depressors and syringes. Some are meant for mass 
markets, others are niche items.  Some are packaged individually; others 
are packaged in boxes of 100s or 1,000s. Some are reprocessed, others 
disposable, and some are used for a lifetime (Bix, 1).” Risks associated 
with device misuse and failures are equally varied, ranging from 
inconvenience to patient death.  
Such a broad range of products and risks make it necessary for the Food 
and Drug Administration (FDA) to segregate devices into varied categories, or 
product classes.  There are three classifications that are recognized by the FDA.  
Class I products are where “general controls are sufficient to provide reasonable 
assurance of the safety and effectiveness of the device” and are not life-
supporting or life-sustaining (21CFR860.3).  These devices are for a “use which 
is of substantial importance in preventing impairment of human health, and which 
does not present a potential unreasonable risk of illness or injury. (21CFR860.3)”  
Class II products are devices where “general controls alone are insufficient to 
provide reasonable assurance of its safety and effectiveness” and are “to be for 
use in supporting or sustaining human life (21CFR860.3).”  Class III products 
require premarket approval as they have significantly higher risk rates than Class 
I and II devices.  These devices are life-supporting or life-sustaining, or for a use 
which is of substantial importance in preventing impairment of human health, or if 
the device presents a potential unreasonable risk of illness or injury 
(21CFR860.3).”  Manufacturers must classify all their products according to the 
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FDA product classes and follow the design testing and validation procedures 
specific to the product class. 
Medical Device Industry 
The medical device industry across the globe was valued as a $140 billion 
business in 2002 with an anticipated growth of 5 percent through 2010 (“Surgical 
and Medical Equipment,” 7).  Today, the United States remains the world’s 
largest consumer of medical products, at 40 percent, and the largest producer, 
manufacturing 50 percent of all medical devices.   
The orthopedic (pertaining to the musculoskeletal system) market 
segment alone was valued at $20 billion worldwide in 2005.  This segment has 
experienced rapid market growth of 13-15 percent during the mid-2000s.  Growth 
in orthopedics is expected to continue and has been attributed to the aging 
population, longer life spans, and higher rates of obesity (“Surgical and Medical 
Equipment,” 8).   
Although the US holds the position of world leader as both a manufacturer 
and consumer of medical equipment, Western Europe, Japan, and China are 
closing the gap.  The European market is anticipated to grow to a value of $37.2 
billion by 2010.  Medical technology and manufacturing capabilities in China are 
growing at such a fast rate that it is expected to surpass the US in medical 
equipment revenues by 2039 (Surgical and Medical equipment, 16). 
Major manufacturers in the medical device industry include companies 
such as Johnson & Johnson, Boston Scientific Corporation, Roche Diagnostics, 
Becton Dickinson Company (BD), and Medtronic (“Surgical and Medical 
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Equipment,” 11-15).  Each of these companies has managed to capture a 
leading position in a specific market within the medical device industry.  Johnson 
& Johnson, the largest player in the industry, manages several companies that 
target multiple segmented markets.  Johnson & Johnson companies include 
Depuy, which specializes in orthopedic joint reconstruction and spinal care 
products (Hoover’s, 2009) and Ethicon, a leader in sutures and wound 
management.  Boston Scientific produces catheters, endoscopes, and 
laparoscopes for the vascular and cardiovascular market segments.  Roche 
Diagnostics was formed by a merger between the Swiss company Roche and the 
German company Boehringer Mannheim, and it accounts for 20 percent of the 
world market in medical diagnostic equipment.  Although Becton Dickinson (BD) 
is a diverse organization servicing multiple industry segments, they are the 
market leaders in the needle and syringe market.  Medtronic leads the world in 
implantable biomedical devices, specializing mainly in pacemakers and 
defibrillators.  (“Surgical and Medical Equipment,” 11-15). 
Medical Packaging Types 
Due to a broad range of medical products, options for medical packaging 
are abundant.  The medical packaging industry is frequently categorized in the 
following ways:  reusable vs. disposable and sterile vs. non-sterile.  The focus of 
this research is on sterile, disposable devices that are terminally sterilized. 
Packaging for Disposable Devices 
Disposable medical devices can be sold by the manufacturer as sterile or 
non-sterile products and are designed for a single-use application.   
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Tray 
Trays used in the medical packaging industry can be manufactured as 
rigid or flexible units that are typically comprised of a silicon coated or uncoated 
polyethylene terephthalate (PET) or a glycol-modified polyethylene terephthalate 
(PETG) base.  Such trays, Figures 1 and 2, are frequently covered using a 
porous material, such as medical paper or Tyvek®, that enables the passage of 
gas sterilant, such at EtO, for terminally sterilized product.  A silicon coating is 
sometimes used to prevent preformed trays from sticking together when stacked, 
or nested, for storage and distribution.  Lid stock is often coated with heat seal 
coating to promote sealing to the trays. 
 
Figure 1:  Snap-fit rigid tray 
 
Figure 2:  Rigid tray 
 
Packaging operations using trays can be managed in one of two ways:  fill and 
seal or form/fill/seal.  Form/fill/seal operations offer manufactures inventory and 
space reduction, increased speeds, and more flexibility within their operations by 
providing the option of forming rigid or flexible trays.  Fill and seal operations 
require the storage of preformed rigid trays, but can provide a cost-effective 
solution for small volume production. 
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Pouch 
Due to their low cost, pouches are by far the most common method for 
packaging high-volume medical products (Sherman, 68).  Many polymer 
structures can be used for pouches, but a dominant material combination used is 
a PET/LDPE (low density polyethylene) structure for one side that is then sealed 
to a coated or uncoated porous material, such as medical-grade paper or 
Tyvek®.  Other popular structures contain Nylon or foil.  Pouch design is strongly 
dependent on sterilization technique.  As described for trays, manufacturers 
choosing pouches for their operations have the option to purchase preformed 
pouches for fill/seal operations or to use roll stock for form/fill/seal operations.   
Two main sealing configurations are popular for pouches used in the 
medical industry, corner peel and chevron.  Corner peel pouches offer the user a 
grip point on one or both corners of the pouch to begin the peel.  However, the 
corner peel pouch (Figure 3) requires that users begin peeling at full seal width, 
which requires more force to initiate opening.  The chevron pouch offers a 
smaller initial peel width, which reduces the amount of initial force required to 
open the pouch (Figure 4).  Unlike corner peel and chevron pouches, tear 
pouches (Figure 6) offer easy access opening by ripping the material.  Tyvek® 
and paper structures are not ideal tear pouch materials due to either the material 
strength or particulate concerns. 
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Figure 3:  Chevron pouch 
 
Figure 4:  Corner peel pouch 
 
Header Bag 
Header bags, sometimes called breather bags, are a pouch variation that 
reduces the use of porous packaging materials, which in turn reduces production 
costs (Figure 5).  With over three quarters of the pouch being made-of non-
porous materials, this pouch offers porosity with increased seal and puncture 
strengths.  These unique structures require the user to open the bag from a flap 
located on the interior of the pouch structure and then fold the porous material 
under the product to achieve aseptic presentation.  Aseptic presentation is the 
act of the nurses opening and handling a sterile package in a manner that will not 
compromise the sterility of its contents. 
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Figure 5:  Header bag 
 
Figure 6:  Tear pouch 
 
Single vs. Double Barrier 
All previously discussed methods for packaging can be used as stand 
alone packages or combined to form a double barrier.    The term “double barrier” 
refers to two barriers that can be considered sterile barriers by the end user.  
Most end users, nurses, of medical packaging prefer double barrier packages 
over single barrier, because it allows them easier aseptic presentation into the 
sterile field (J. Neid and J. Blocher, Healthpack presentation, March 2009).  
Tertiary packaging, such as paperboard boxes, are not considered a second 
barrier by the medical packaging industry. 
Reusable 
Medical devices that are reusable are designed to be sterilized within the 
hospital system (ie. instruments) and as such, they do not require the sterility 
measures as the terminally sterilized products.  Without the need to pre-sterilize 
product, reusable devices can be packaged in a multitude of ways.  Many of the 
packaging options previously discussed are also used to package reusable 
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devices.  However, heavier devices or devices that require more cushioning may 
use foam cutouts, foam-in-place, or corrugate structures to cushion and/or 
restrain reusable devices during distribution. 
Materials 
Tyvek® 
Tyvek® is a unique material that offers water resistance while maintaining 
strength and permeability.  In 1955, DuPont researcher Jim White, discovered 
Tyvek® by accident when he noticed a “polyethylene fluff” escaping a pipe in the 
research labs (DuPont, 3).  Although Tyvek® looks and feels similar to paper, it is 
constructed from pure high-density polyethylene (HDPE) fibers and maintains a 
higher strength-to-weight ratio than paper.  Like paper, Tyvek® is 100% 
recyclable given an appropriate recycling program.  Recycling programs that 
accept the SPI #2 symbol for HDPE are capable of recycling most Tyvek® 
materials (DuPont, 3).   
While its recyclability makes it attractive to companies striving to produce 
more sustainable products, it is Tyvek®’s ability to maintain strength while 
offering porosity and moisture resistance that make it attractive to the medical 
packaging industry.  Porosity is a necessity for any manufacturer wishing to 
sterilize via Ethylene Oxide (EtO), which is the sterilization choice for 
approximately 50% of all disposable medical device products (“Sterilization 
(microbiology),” 2009).   
Tyvek® is manufactured and distributed worldwide solely by E.I. DuPont 
de Nemours and Company, Wilmington, Delaware.  Although DuPont sells 
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Tyvek® directly, sales and distribution of the substrate mostly occurs through 
converters, such as Perfecseal and Mangar, who provide the medical device 
industry with various forms of packaging for terminally sterilized devices.  
(DuPont) 
There are four grades of Tyvek® that are considered acceptable for the 
medical device industry:  1073B, 2FS, 1059B, and Asuron.  Each of the grades 
offers variation in microbial barrier, porosity, thickness, and many other 
properties.  Asuron is the only grade that is not 100% HDPE.  It contains titanium 
dioxide (TiO2) to improve appearance of structure uniformity.  (DuPont) 
Manufacturing Process 
DuPont has a patented process, known as flash-spinning, for the manufacture 
of all Tyvek® grades, Figure 7.  The process begins with spinneret extrusion 
technology.  Unlike the textile spinneret extrusion processing this spinning 
process involves a continuous strand of material which is used to create a non-
woven structure of synthetic fibers.   
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Figure 7:  Flowchart of spinbonding process  
 
A non-woven structure is defined by Wikipedia as a “term used in the textile 
manufacturing industry to denote fabrics, such as felt, which are neither woven 
nor knitted.”  Initially, the synthetic material is melted, filtered for impurities, and 
extruded through tiny holes in the spinneret as shown in Figures 8-9 
(FiberSource, pars. 1-4).   
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Figure 8:  Extrusion through spinneret 
Photo used with permission from AKZO Nobel 
 
 
Figure 9:  Post spinneret extrusion 
Photo used with permission from AKZO Nobel 
 
 
DuPont’s proprietary manufacturing process involves extrusion with the 
use of a solvent that immediately evaporates from the extruded polyethylene.  
The solidified substance is then laid onto a moving belt with the aid of a 
computerized system that optimizes “random” layering of the web, thus creating 
a torturous path (Figure 10) through the material.  The web is then bonded 
together using heat and pressure.   
 
Figure 10:  Tyvek® (200x magnification) 
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Copyright © 2005 E.I. du Pont de Nemours and Company.  All rights reserved.  Reprinted by permission. 
 
Tyvek® grades are varied by using the same manufacturing process and 
varying the belt speeds and the heat and pressure variables.  Unlike other forms 
of Tyvek®, medical-grades are not corona treated or anti-static treated because 
these treatments are suspected to cause potential concerns with the material 
properties (DuPont, 3). 
Ovantex® 
Launched in April 2006, Ovantex® is a newer medical-grade packaging 
material converted and marketed by Oliver® Medical.  Designed to be both 
porous and sterilizable, Ovantex® is marketed as a low cost alternative to 
medical-grade paper and Tyvek® for medical pouching and lidding applications.  
Oliver® recommends the potential use of Ovantex® for such products as sutures, 
syringes, irrigation sets, wound dressings, orthopedics, cannulas, and device 
accessories (Oliver®, www.oliver-tolas.com). 
Manufacturing Process   
Although the exact method to manufacture Ovantex® remains 
undisclosed, Oliver® states that Ovantex® is composed of a cellulose and 
synthetic fiber web (Oliver®, Ovantex® Facts).  Such a process would result in a 
medical-grade paper laced with an unknown synthetic fiber in a non-woven 
structure.   
Medical-Grade Paper 
 Little to no information is available to distinguish medical-grade paper from 
other paper grades, however there is speculation that the determination is based 
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on fiber length (to reduce particulate concerns), puncture and tear resistance, 
and porosity.   
 Paper is manufactured through a set of basic manufacturing processes.  
The process begins with pulping, which breaks down the wood into its fibers.  
The fibers are then suspended in water and refined.  Additives, such as fillers, 
are then added.  The slurry is then placed on a mat, drained of excess water, and 
dried thoroughly.  (Bowyer) 
Sterilization Methods 
Ethylene Oxide (EtO) 
Ethylene oxide is a colorless, odorless, highly flammable, and explosive 
gas that the medical device industry and hospital systems use to achieve product 
sterilization at reasonably low temperatures.  Sterilization at low temperatures 
makes EtO sterilization very attractive for heat sensitive products.  Five main 
variables are used to achieve safe and effective EtO sterilization:  Gas mixture, 
gas concentration, temperature, humidity, and exposure time (Dyro, 534).   
To reduce the explosive properties of EtO, it is often combined with other 
gasses, such as Nitrogen (N2), Carbon Dioxide (CO2), or 
Hydrochlorofluorocarbon (HCFC) (Sherman, 160).  For CO2 to render EtO inert, 
90% of the gas mixture must be CO2 which greatly diminishes the EtO potency.  
HCFC mixtures allow for safe sterilization while maintaining a higher 
concentration of EtO, but is expensive and hazardous to the environment.  For 
these reasons, most sterilizers use 100% EtO that is later neutralized in the 
sterilization chamber with N2.  This method requires a significant investment in 
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capital to improve equipment safety measures, but also allows manufacturers to 
reduce their cycle times.   
In 1949, Kaye and Phillips established that, as relative humidity (RH) 
levels increase, sterilization through EtO is achieved much faster (Sherman, 
158).  For this reason, sterilizers often precondition products to an RH of 70% 
and conduct sterilization at the same RH level. 
Biological Indicators (BI’s) are used to ensure the lethality of the 
sterilization cycle and to eliminate the need for actual sterility testing on product 
from daily production runs.  A typical BI is made from paper that has been 
impregnated with a known population of bacterial spores of a certified resistance 
value (Sherman, 144).  BI’s are placed throughout the sterilization loads, 
especially in locations that may be difficult for vapors to penetrate.   
The low temperature processing requirements to accomplish sterilization 
is the main advantage for EtO sterilization.  The main disadvantage is the toxicity 
of EtO.  EtO is considered by the Occupational Health and Safety Administration 
(OSHA) to be a “potential human carcinogen (Sherman, 170).”  If not properly 
aerated, EtO can cause serious chemical burns, to workers, healthcare providers 
and patients, when it contacts skin for even a short duration.  Aeration refers to 
allowing the product sufficient time for any hazardous residues associated with 
the sterilization cycle to escape the package naturally through the porous 
material structure.  The EtO aeration cycle is dependent on many factors such as 
dose mixture, exposure time, product make-up, and the product’s intended 
usage.  The ANSI/AAMI/ISO 10993-7 (Standard for Biological Evaluation of 
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Medical Devices, Part 7: Ethylene Oxide Sterilization Residuals) outlines the 
acceptable residual levels and the necessary aeration times required.  Aeration 
cycles can range from two hours to seven days, which has led many hospitals 
and device manufacturers to move towards alternative sterilization methods. 
Gamma Radiation 
Gamma radiation can be achieved through radioactive isotopes (Van de 
Graaf and microwave linear generator) and radioisotopes (Cobalt-60 or Cesium-
137) (Sherman, 176).  Both types of equipment achieve sterilization by creating 
free radicals that react with the nucleic acids of the microorganisms that lead to 
their destruction (Sherman, 173).  Accounting for about 50% of the sterilization 
market, gamma radiation is quickly replacing Ethylene Oxide as the primary 
sterilization method in the medical device industry (Dyro, 534).   
Unlike EtO and other gas sterilization methods, gamma radiation does not 
require the use of biological indicators (BIs) but instead uses dosimetry to ensure 
products receive the appropriate dosage of radiation.  Dosimetry is the activity of 
using a dosimeter to measure the amount of absorbed radiation.  The dosage is 
typically measured in gray (Gy).  According to AMMI/ANSI/ISO 11137 – 
Sterilization of Health Care Products, 25 kGy is typically sufficient for small- 
volume production (Sherman, 175).   
Benefits of gamma radiation include:  rapid processing, system flexibility, 
no temperature concerns, increased throughput, and immediate availability of the 
product due to lack of aeration quarantine.  Gamma radiation also has the added 
benefit of allowing manufactures more options in material selection as porous 
 26
materials are no longer a requirement.  However, alternative means for 
sterilization are not problem-free, gamma radiation can embrittle and yellow 
many plastics.  As a result, it is critical that all plastics are tested using the 
maximum possible dosage for the recommended lifetime of the product.   
 Steam Sterilization 
For heat tolerant medical device products, steam sterilization is the most 
economical option for product sterilization and does not require the need for 
storage or handling of any dangerous compounds (Dyro, 533).  Steam 
sterilization is frequently used in hospitals to sterilize equipment for surgery.  The 
most common steam sterilization method is steam under pressure.  For this 
method, an autoclave is used to remove air from the exposure chamber and then 
to subject a device to steam under extreme temperature and pressure variables.  
Steam created in the autoclave chamber transfers its thermal energy to the 
microorganisms, which results in their inoculation (Dyro, 533).  This method 
remains the most economical sterilization option because it requires only water 
and roughly 20 minutes to complete the steam cycle.  Disadvantages to this 
method are the requirement of BIs and the extreme temperature and pressure 
conditions, around 250 degrees F at 106 kPa pressure, required. 
Vaporized Hydrogen Peroxide (VHP) 
Vaporized hydrogen peroxide is used to sterilize surfaces by the 
production of a hydrogen peroxide gas cloud or low temperature plasma that 
surrounds the products in sterilization.  The process begins by placing the 
sterilizable packaged product into the sterilization chamber.  A vacuum is then 
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used to remove all air.  The outer chamber is then injected with a 58% hydrogen 
peroxide water mixture (Dyro, 535).  This mixture is vaporized and dispersed 
throughout the sterilization chamber.  Once the mixture has been fully dispersed 
in the chamber, plasma is then generated through an electromagnetic field 
initiated through the use of a radio frequency (RF) generator.  
Advantages to the VHP sterilization system include:  short cycle time at 
approximately one hour, low temperature, eco-friendly with the only by-product 
being oxygen and water, less hazard to metal products than steam sterilization, 
and easy installation in various locations due to the standard 208-volt 
requirements.  Disadvantages are that HP requires the use of BIs and cannot be 
used with several materials, (ie. nylon, cellulose, polycarbonate, etc) because the 
materials can become brittle or experience absorption issues (Dyro, 535).  VHP 
is a surface sterilization technique; device design is of great importance, as the 
product must not have surfaces where vapor cannot penetrate. 
Package Integrity 
ISO 11607 Parts 1 and 2 serve as the primary guidance for determining 
the requirements of medical device packaging.  As of 2006, this standard was 
updated to include Annex B, which includes recommended standard test 
methods that can be used to comply with the requirements of ISO 11607.   
Microbial Penetration 
Since porosity is a requirement for some sterilization methods, microbial 
penetration through the given porous material must also be studied.  ASTM 
F1608-00: Standard Test Method for Microbial Ranking of Porous Packaging 
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Materials is currently the industry’s accepted method, also found in ISO 11607 
Annex B, for determining microbial barrier properties of porous materials.  
However, as of 2007, a new alternative standard was introduced, ASTM F2638-
07: Standard Test Method for Using Aerosol Filtration for Measuring the 
Performance of Porous Packaging Materials as a Surrogate Microbial Barrier.  
Both methods offer different capabilities, advantages, and disadvantages. 
F1608 
The F1608: Standard Test Method for ‘Microbial Ranking of Porous 
Packaging Materials’, also called the Exposure Chamber or Forced Flow Method, 
tests the penetration of Bacillus subtilis var. niger spores through a chamber 
containing five 47-50-mm diameter samples.  The five samples and one control 
sample are placed in each of the six ports in the exposure chamber, Figure 11. 
 
Figure 11:  Exposure chamber for F1608 test standard (ASTM F1608-00) 
Figure 11 under copyright of ASTM International.  Formal authorization to reproduce Figure 11 was 
approved by ASTM Headquarters on June 4, 2009 
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The number of bacterial spores the samples are subjected to during 
testing is considered the “challenge,” while the number of the challenge spores 
that penetrate the sample is called the “filtrate.”  The concentration of the 
challenge is often measured as the number of colony forming units, or CFU.  In 
this method, a challenge of 1x106 CFU/sample/port, are forced through the 
porous material sample at a flow rate of 2.8 L/min for an exposure time of 15 
minutes (F1608, 3-4).  Samples are then incubated for a minimum of 24 hours at 
30-35⁰C to allow appropriate time for bacterial colonies to grow.  A bacterial 
colony is a group of bacteria that is assumed to be derived from one bacterial 
spore.  Following the incubation period, the number of colonies are counted, 
recorded, and used to calculate the log-reduction value (LRV).  The LRV 
expresses the ability of a material to reduce penetration of the bacterial spores 
through the substrate and is calculated using the formula: 
      (Equation 1) 
Where: 
N0= avg. bacterial challenge determined from the challenge control filter, CFU 
N1= avg. number of bacteria passing through Test Sample 1, CFU.  If N1<1, then 
LRV is expressed as >log10No. 
(F1608-00, section 12) 
 
The LRV values are then used to rank the microbial penetration properties of 
the porous materials.  Higher LRV values represent a higher microbial retention 
by the material.  Table 1, demonstrates a material’s ability to reduce the number 
of bacterial spores that could enter a sterilized packaging, thus compromising the 
sterility of its contents. 
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Table 1:  Log reduction value correlation to percent spore retention (ASTM F1608, Section 12.8) 
LRV Spores Retained, 
% 
1.0 90 
2.0 99 
3.0 99.9 
4.0 99.99 
 
The main advantage to this test method is that the consistent flow rate allows 
for easy cross-material comparisons, which can aid manufacturers when 
choosing materials.  Disadvantages are that it is a labor intensive process that is 
time consuming and costly.  Additionally, this method has been criticized for 
using elevated flow rates and dispersion concentration levels that may not be 
representative of “real-world” applications.  Additionally, the industry has 
indicated the use of microbes to be problematic because it requires a relatively 
high level of skill, and can result in variable results. 
Testing with Bacterial Spores vs. Particles 
In an effort to address the disadvantages of testing with ASTM F1608-00, 
researchers from the University of Manchester sought to determine an alternative 
method that was more cost effective, time efficient, and allowed for variation of 
flow rates for more “real-world” application.   
Given that “microbial cells are highly consistent in size,” the researchers 
sought to develop a correlation between microbial spore penetration and fixed 
size particle penetration through commonly used porous packaging materials 
(“Definition of Correlation”, 12).  The general idea was that particles, which can 
be more consistent and don’t require the same degree of care in storage and 
handling, could be correlated to microbial penetration, simplifying the test and 
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decreasing the variability of results.  Tallentire and Sinclair sought to find a 
correlation independent of fiber properties, sheet porosity, and material depth or 
thickness (“Definition of Correlation”, 12).  For this reason, they conducted their 
research on 28 varieties of porous materials.  Twelve materials were designed by 
the researchers to “provide a range of structures exhibiting grade barrier 
performance (“Definition of Correlation”, 12),” while the remaining sixteen 
materials were provided by industry members.  The industry materials comprised 
of papers, coated papers, nonwovens, and coated nonwovens.   
All material samples were subjected to a challenge of Bacillus subtilis var. 
niger spores at a concentration of 106 spores dm-3 and flow rates ranging from 
10-4 to 3x10-1 dm3 min-1 cm-2.  Material samples were changed for each flow rate 
challenge.  The material samples were then subjected to a particulate, 
diethylhexylsebacate (DEHS), challenge.  Particulate size ranged from 0.04-0.6 
µm, and both the challenge particle number and the filtrate particle number were 
counted “real time” with the use of two independent particle counting systems.  
Any particle counting system is appropriate as long as it has the ability to 
distinguish between water droplets and the PSL particles.  The ASTM F2638-07 
test standard recommends using an optical particle counter which uses a high-
intensity light source, or laser.  The PSL particles will reflect the light emitted from 
the laser, which is detected by a photodetector, a highly-sensitive light gathering 
detector, and recorded into the data logging system. Data collected, using the 
dual particle counting system, was then used to calculate the flow rates and the 
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percent of penetration through the samples for both the physical and 
microbiological tests.   
Researchers determined a correlation between physical and 
microbiological penetration percentages.  This correlation was found by plotting 
the maximum particulate penetration percentage, partPmax (x-axis), versus the 
maximum spore penetration percentage, partPmax (y-axis), for a 4x10-3 dm3 min-1 
cm-2.  This was done for 16 commercial papers and again for the 12 designed 
papers to demonstrate independence from fiber properties, sheet porosity, and 
material thickness.  The researchers concluded that “overall findings 
unequivocally show that the physical/microbiological barrier correlation is 
applicable to the diverse structures of commercial porous packaging materials. 
(Definition, 17)” 
F2638 
ASTM F2638 uses 1µm polystyrene latex (PSL) particles in place of 
microbes to determine the microbial penetration rate through a given material.  
This test standard can be performed as a single particle counter system or a dual 
particle counting system.  In either case, a single 120mm diameter sample is 
exposed to a particulate challenge with a concentration of 200-8000 particles/ml. 
A predetermined pressure differential, or change in pressure across the sample, 
is held for a minimum period of 45s, once the system has stabilized, typically 2 
minutes.  Using a dual counter system, the particulate challenge and the 
particulate filtrate are measured concurrently, but for a single counter system the 
particle counter must be switched between the challenge and penetration counts 
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throughout the test.  After the exposure period has elapsed, the flow rate is 
lowered by reducing the pressure differential by a factor of 2.  Once the new 
system pressure has stabilized, readings consistent for 2 minutes, the test 
repeats testing with particulate exposure for a minimum of 45s.  This process is 
repeated until average filtrate particle count is less than 25 particles in 60s or the 
pressure differential can no longer remain stable.  Since industry familiarity is in 
analyzing the flow rate through the sample, the pressure differential across the 
sample is converted to flow rate, using calculations shown by Equation 3.  
Penetration percentages are calculated using: 
      (Equation 2) 
Where: 
R(n)= penetration percentages 
CF(n)= penetration particle count 
Cc(n)= particulate challenge count 
 
       (Equation 3) 
Where: 
F(n)= flow rate across the sample 
Ft= calibrated flow of the particle counter 
P1= pressure across the sample 
P(n)= test pressure 
 
The penetration percentage (R) and flow rates (F) are then plotted on a 
log-log scale, where the x axis is flow rate and the y is penetration percentage.  
This graph is then used to determine the apex of the best fit line.  This apex 
corresponds to the flow rate for which maximum penetration through the sample 
Pmax is achieved under these test conditions. 
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Microbial Barrier Comparisons 
Tyvek® obtains its microbial barrier properties by creating a tortuous path 
that traps microbes as the air weaves through the material (DuPont, 19).  This 
type of microbial barrier is important to allow the material to be both porous, for 
vapor sterilization techniques, while maintaining product sterility.  Figure 12 
depicts how this type of microbial barrier is achieved.   
 
Figure 12:  Microbes trapped in tortuous path of Tyvek® at 500x magnification  
Copyright © 2005 E.I. du Pont de Nemours and Company.  All rights reserved.  Reprinted by permission. 
 
Both the manufacturing processes and variation in materials used to 
manufacturer the various porous materials are why all four materials result in 
different microbial barriers properties, demonstrated by Figure 13.  In the past, 
microbial barrier data provided by the manufacturers was generated by ASTM 
F1608-00, a test which, as mentioned, has a constant flow rate.  Microbial barrier 
properties can also be greatly influenced by dispersion concentration, dispersion 
flow rate, and material structure variations. 
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Figure 13:  Microbial barrier material comparison (Exposure Chamber method)  
(www.dupont.com) (www.Oliver®-tolas.com) 
 
Influence of spore dispersion concentration and dispersion flow rate on microbial 
barrier performance 
 
As more research is conducted, concerns with the test methods and the 
test method variables come into question.  When discussing microbial barrier 
penetration, the industry has generally accepted test method ASTM F1608-00.  
This method challenges porous material samples at a fixed flow rate and spore 
concentration level, 102 and 106 spores/L and the dispersion flow rate at 2.8 
L/min for a 10 cm diameter sample.   
Research by the Lewisham Hospital system (1973) was conducted to try 
and determine the typical concentration level of packages in multiple locations 
within the hospital system.  The findings were that 35-65 colonies (0.19-0.36 
organisms/min) were found on packages being stored in the central sterile supply 
area and 2-15 colonies during aseptic presentation in preparation for a surgery.  
The highest colony count, during this study, came from the dressing area in the 
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accident department (or emergency room), 120 colonies (Monty and Mayers, 18-
9).   
Exposing the porous packaging materials according to ASTM F1608, 
challenges the materials at 28,000,000 spores/min.  With such a large 
discrepancy between the observed spore concentrations and test concentrations, 
the medical packaging industry is understandably concerned with the applicability 
of the current test standard (F1608) in the “real-world.” 
In 1986, Tallentire and Sinclair examined the influence of dispersion 
concentration in their published article (“Influence of Dispersion Concentration”, 
34-37).  By first isolating the dynamic variables of the test, spore concentration 
levels and flow rate, they were then able to challenge the webs at varying spore 
concentrations and flow rates.  Three uncoated webs were tested in the study:  
two commercial medical-grade papers and Tyvek® 1059B.  Isolating the spore 
concentration and flow rate variables involved selecting the samples from various 
locations of the sample rolls and using air permeability measurements to select 
samples of similar structure.   
Testing showed that the percent penetration values “at a particular flow 
rate with different spore-challenge concentrations are generally close to one 
another and apparently fall randomly around a common value (“Influence of 
Dispersion Concentration”, 36).”  The researchers concluded that at the 
predetermined flow rate “percent penetration was independent of flow rate.”  The 
conclusion is that, although some standards may require extremely high spore 
concentrations for microbial barrier testing, these results can be used to predict 
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the microbial barrier performance at lower “real-world” spore concentration rates 
(“Influence of Dispersion Concentration”, 37). 
Affect of Material Structural Variations on Microbial Penetration Properties 
Much of the research performed by Tallentire and Sinclair has suggested 
that a material’s microbial barrier properties are “dependent in part on its ability to 
act as a depth filter. (“Variations in Structure”, 57)”  If this is accepted as true, 
there is the question as to how microbial penetration is affected by variations in a 
material’s structure.  Manufacturing processes for medical-grade papers allow for 
a fairly consistent structure throughout a roll, but the very nature of Tyvek® 
makes structural consistency virtually impossible.  In the article “Variations in 
Structure and Microbial Penetrability of Uncoated Spunbonded Polyolefin 
(Tyvek®),” Tallentire and Sinclair explored the effect a material’s structure had on 
its microbial filtration capabilities. 
Tallentire and Sinclair tested both 1059B and 1073B uncoated Tyvek® 
grades.  In an effort to minimize the effects of flow rate, they tested at four 
significantly different flows:  1, 6, 20, and 100 cm3 min-1 cm-2.  Their intent was to 
use air permeability and thickness measurements to characterize the various 
densities of Tyvek® samples.  Then they subjected the characterized sample to 
microbial penetration testing to determine if a correlation existed.  They tested 50 
samples of each material, from various locations on the rolls, for both air 
permeability and microbial penetration. 
They determined that both flow rate and thickness of a material have a 
“major role in determining microbial penetrability toward airborne bacterial spores 
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(“Variations in Structure”, 61).”  They further conclude that the web structures for 
medical-grade Tyvek® and microbial penetrability “can be correlated.” 
This information confirms that material structure is a dynamic variable 
when testing materials with respect to microbial penetrability and must be 
factored into the test design accordingly.  
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 MATERIALS AND METHODS 
 
Equipment 
Preconditioning 
Achieving the desired RH levels, 15%, 50%, and 90%, required 
construction of three temporary atmospheric chambers.  These chambers were 
built using three 20 gallon aquariums (Figure 13) and various salt solutions.  
Silicon grease and fiberglass were used to form an air tight seal around the top of 
the three aquariums.  With the temperature remaining constant at 23 ± 1 ⁰C (73.4 
± 2 ⁰F), it was determined that Lithium Chloride, Magnesium Nitrate, and 
Potassium Nitrate would be the saturated salt solutions required to achieve levels 
close to the, low (15%), nominal (50%), and high (90%) RH levels desired 
(Greenspan, 89).  Sper Scientific and Oakton hygrometers were placed in the 
temporary environmental chambers and used to read the real-time RH and 
temperature values.  
 
 
Table 2:  Identification of salt solutions to relative humidity levels (Greenspan 89-93) 
Saturated Salt Solution Relative Humidity % (at 20⁰C) 
Lithium Chloride,  LiCl 11.31 ± 0.31 
Magnesium Nitrate,  Mg(NO3)2 54.38 ± 0.23 
Potassium Nitrate,  KNO3 94.62 ± 0.66 
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Figure 14:  Conditioning chambers 
 
 Tie racks, purchased from Home Depot, were used to keep the samples 
separated and vertical during preconditioning, which would ensure that all 
surfaces of the sample were exposed to the environments moisture. 
Testing 
Testing primarily followed the ASTM F2638-07 test standard, which 
outlines a specific configuration of equipment for both dual and single particle 
counting systems.  Since this test standard is relatively new, the DuPont facility in 
Richmond, Virginia is the only location in the world with the equipment 
arrangement required by ASTM F2638-07.  Thus, it was necessary to conduct 
the conditioning and testing using the dual particle system at DuPont’s Richmond 
facility. 
The equipment is configured, as demonstrated in Figure 14, using a 
nebulizer, two particle counters, data logging system, manometer, pressure 
regulator, and a customized sample holding fixture.  All flow readings were in 
direct engineering units, standard liters/minute. 
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Figure 15:  Equipment configuration for F2638-07 (ASTM F2638-07) 
Figure 15 under copyright of ASTM International.  Formal authorization to reproduce Figure 15 was 
approved by ASTM Headquarters on June 4, 2009 
 
Nebulizer 
A vertical nebulizer is used as the aerosol generator which disperses the 
particles from their liquid solution.  Periodically, an ultra sonic cleaner, seen in 
Figure 15, is used in conjunction with the nebulizer to ensure the particles remain 
suspended within their liquid solution.   
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Figure 16:  Nebulizer with ultrasonic agitation  
 
Particle Counters 
Method B of ASTM F2638-07, requires the use of two particle counting 
units, measuring the challenge and filtrate counts respectively.  DuPont’s system 
used two Lasair series Model 1003 particle counters from Particle Measuring 
Systems, Figure 16.  This system is capable of counting and classifying particles 
that are 0.7 µm and 1.0µm in diameter. 
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Figure 17:  Dual particle counters (Lasair series) 
 
Data Logging Software 
DuPont has developed custom software that collects the elapsed test time 
(hours/minutes/seconds of the day), pressure differential (psig), total challenge 
particles (#), total filtrate particles (#).  The software also calculates the flow rate 
(lpm) across the test sample, Figure 17.  The system then records and graphs 
these measurements every six seconds throughout the duration of the test, 
Figure 18. 
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Figure 18:  Data tracking software interface 
 
 
Figure 19:  Data tracking graph 
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Manometer 
The manometer is used to measure the pressure differential across the 
sample.  Precision of the manometer is critical and it must maintain a minimum 
range of 0 to 5 cm WC with an accuracy of 0.005cm WC (ASTM 2638-07).  
Readouts from the manometer were displayed on the data logging screen and 
adjustments were made to pressure using a series of controls from the 
equipment control panel, Figure 19. 
 
Figure 20:  System control panel 
 
Customized Sample Holder 
Samples are held by a custom sample holder, which exposes a 100cm 
diameter area of the sample to the desired particulate challenge. The holder 
consists of two assemblies that deliver a uniform flow of aerosol across the test 
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specimen (ASTM 2638-07: 7.1.1).  A dimensioned drawing of the sample holder 
is available in ASTM F2638-07: Figure 2. 
 
 
Figure 21:  Closed custom sample holder 
 
 
Figure 22:  Opened custom sample holder 
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Materials 
Samples 
Tyvek® and medical-grade papers were chosen for the testing due to their 
prominent use in medical device packaging, while Ovantex® was chosen 
because of its recent introduction to the medical packaging market and lack of 
research available about its properties.  The materials tested include uncoated 
Tyvek® 1073B, coated Tyvek® 1073B, dot coated Ovantex®, and coated 55 
pound latex impregnated medical grade paper.  Since sealability limits the use of 
uncoated medical-grade paper in the medical industry, testing was only 
performed on a coated form.  Fifty-five pound latex impregnated medical-grade 
paper was chosen because it has the highest sales volume for medical-grade 
papers in the medical device industry (S. Belmonte, Perfecseal, personal 
communication, 2009).  Given that that Tyvek® is used frequently as both an 
uncoated and coated substrate, both structures were chosen for testing.  The 
coatings on both the Tyvek® 1073B and the medical-grade papers were CR27 
from Perfecseal, which is the most common coating sold in the medical device 
industry (S. Belmonte, Perfecseal, personal communication, 2009). Ovantex® is 
coated with a dot coating that is exclusive to Oliver® Medical. 
Particulate 
As outlined by ASTM F2638-07, the particulate used in testing was made 
of polystyrene latex (PSL) particles measuring at 1µm in diameter.  The product 
used was product 5100A Duke Scientific. 
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Defining Variables 
Preconditioning-Humidity 
The test was aimed at challenging the microbial penetration of materials at 
extreme and nominal relative humidity levels.  Because this testing was focused 
on relative humidity levels, the temperature was set at standard lab conditions, 
23 ± 1 ⁰C (73.4 ± 2 ⁰F), and testing humidity levels were chosen in accordance to 
ASTM D4332-01: Standard Practice for Conditioning Containers, Packages, or 
Packaging Components for Testing.  To perform this test, samples were 
conditioned at three RH levels:  low, nominal, and high.  The D4332-01 standard, 
states that relative humidity of 50 ± 2% is a standard conditioning atmosphere, so 
that level was selected for the nominal value for this testing.  Extreme RH levels 
were similarly determined using Table 1 of the D4332 test standard.  This table 
refers to a RH of 90 ± 5% as a “high humidity” or “tropical” environment, and a 
RH of 15 ± 2% as a “desert” or “low humidity” condition.  Test samples were 
exposed in the environmental chambers, discussed in Equipment section, for a 
period of at least 48 hours.   
Testing-Particulate Challenge 
A concentration level of 10,000 particles per cc was selected.  As 
discussed in literature review, over challenging the samples was not a concern, 
since microbial penetration rates are independent of dispersion concentration 
levels. 
Testing-Flow Rates 
Testing protocol followed ASTM 2638-07 procedure for Method B Dual 
Particle Counter (Section 11.2) with a slight variance; samples were only tested 
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for a single flow rate.  This decision was made to reduce the likelihood of drying 
out the preconditioned material sample and to reduce the potential for particle 
blockage due to a “particle packed” sample.   
Since all previous studies concealed the material identification, it was 
necessary to perform the ASTM 2638-07 test standard on each of the 
unconditioned materials to approximate the maximum particle penetration flow 
rate (Pmax) value.  Since the Pmax value is the point of optimum particle 
penetration, it is critical to incorporate these values during testing to ensure the 
worst-case scenario is being tested.  Once this value was determined, the 
material specific flow rate range was selected for testing.   
Each material was run following the ASTM 2638-07 test standard with the 
challenge concentration levels at 10,000 spores dm-3.  The only deviation from 
the ASTM test standard was that the test was begun with at the minimum flow 
rate, 0.03 slpm, as opposed to beginning at a higher pressure differential and 
flow rate.  The flow rate was then doubled until a peak was observed in the 
filtered particle counts, followed by a continuous decrease.  With this information, 
it was possible to approximate the Pmax by calculating the percent of particle 
penetration and graphing it verses the flow rate, from the test output (Figure 23).  
Previous research in this area presented graphs in log-log format.  This research 
used standard graphing, however log-log graphs can be found in the appendix. 
  (Equation 4) 
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Figure 23:  Optimum flow rate for microbial penetration (additional material graphs in the 
appendix) 
 
Although the previous research done calculating Pmax values hid the identity 
of the materials tested, most of the presented data shows the Pmax values 
ranging within 10-2 and 10-1 dm3min-1cm-2.  As is visible from the log-log graphs, 
in the appendix, this research also determined the materials’ Pmax values to be 
within this range.  This close replication from previous research provided 
additional confidence in the test administration.  The information was then used 
to select the material specific flow rates for the relative humidity tests, Table 3.  
Flow rates selected for the Tyvek® 1073B, were duplicated for the coated 
Tyvek®, 1073B CR27, because there were no filtrate particles observed for the 
coated Tyvek®.  
 
Table 3:  Samples and flow rates chosen for testing 
Sample Flow Rates (lpm) 
1073B 0.06, 0.12, 0.24, 0.48, 0.96 
1073B CR27 0.06, 0.12, 0.24, 0.48, 0.96 
Ovantex® 0.03, 0.06, 0.12, 0.24, 0.48 
55# latex impregnated paper 0.03, 0.06, 0.12, 0.24, 0.48 
 
Statistical Randomization 
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Since complete randomization is ideal for most experiments, testing was 
randomized using a complete block design.  In a complete block design, each 
flow rate is applied to individual samples that are selected at random within each 
run for each round (Larget, 2).”  The test was comprised of three rounds, where 
60 samples were tested in each round.  Each round was comprised of 5 runs at 
various increasing or decreasing flow rates.  The 5 runs within each round 
alternated between ascending and descending flow rate ranges.  There were 
three relative humidity changes within each flow rate change in the run.  Relative 
humidity samples were completely random.  Table 4, below, is designed to 
provide a visual representation of one round for this test.  
 
Table 4:  Complete block design, example of round 
0.03 0.06 0.12 0.24 0.48 0.96 
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R
U
N
 1
 
                                   
0.96 0.48 0.24 0.12 0.06 0.03 
R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R
R
U
N
 2
 
                                   
0.03 0.06 0.12 0.24 0.48 0.96 
R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R
R
U
N
 3
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Test Method 
Sample Preconditioning 
• One hundred and eighty 140mm square samples, 45 samples for each of the 
four materials, were cut using a 140mm square template. 
• In an effort to characterize the materials being tested, thickness and weight 
measurements were recorded for all the material samples prior to 
conditioning. 
• The samples were then equally separated, 15 sample of each material, into 
the three RH chambers for preconditioning, for a minimum of 48 hours.  
Hygrometers were used to provide a “real-time” readout of the chambers RH 
levels. 
Testing Preparation 
• Following ASTM 2638-07 test method B, a 200-8000 particles/ml solution was 
made using the polystyrene latex particles and distilled water.   
• The particulate solution was connected to the nebulizers, and all the machine 
components were activated. 
• Once the particle count readouts stabilized, adjustments were made to the 
flow through the nebulizer to adjust for a 10,000 particles per dm-3 
concentration. 
• Once the challenge and filtrate particle counters stabilized and were within 
3% variation of 10,000 particles per dm-3, testing began. 
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Testing 
• Testing was performed by selecting material samples according to the 
complete block experimental design discussed previously. 
• Samples were removed from the relative humidity chamber and weighed on 
an analytical balance. 
• Weights were recorded and the samples were secured into the sample holder 
for the duration of the test, 3 minutes.  Two minutes were used to stabilize air 
flow and particulate levels, and one minute for the particulate challenge. 
• Time range for the testing was recorded, so data could be extracted for 
analysis. 
• Samples were removed from the sample holder and weighed. 
• Post-test weights were recorded. 
• The process was replicated for all 180 samples tested following the complete 
block experiment design 
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RESULTS AND CONCLUSIONS 
 
Characterizing the Samples 
The initial data collected to characterize the material samples shows that 
all four materials remain relatively consistent in weight.  However as expected, 
due to the structural variations, the Tyvek® 1073B and 1073B CR27 are highly 
variable with regard to thickness. 
 
Figure 24:  Initial material characteristics- Tyvek® 1073B uncoated 
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Figure 25:  Initial material characteristics- Tyvek® 1073B coated  
 
 
Figure 26:  Initial material characteristics- coated medical-grade paper 
 
 56
 
Figure 27:  Initial material characteristics- dot coated Ovantex 
 
Table 5:  Observed measurements for characterizing the samples 
  
Avg 
Weight 
Std 
Dev 
Weight
Avg 
Thickness
Std Dev 
Thickness
Basis 
Weight 
  (g)   (mils)   (g/m2) 
1073B 1.434 0.061 6.641 0.612 0.073 
1073B CR27 1.650 0.058 7.296 0.709 0.084 
Coated 55# Paper 1.819 0.011 4.988 0.075 0.092 
Coated Ovantex 2.03 0.01 5.41 0.11 0.10 
 
Conditioning Effects 
Since salt solutions were used to maintain the relative humidity levels in the 
environmental chambers during preconditioning, slight variations from the 
planned relative humidity levels were expected.  The following table provides the 
data collected from the hygrometer during the designated day of testing.  
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Table 6:  Actual recorded RH levels during testing 
  Day 1 Day 2 
Low 19% 21% 
Nominal 51% 52% 
High 87% 86% 
 
Although initial weights were measured at an undetermined relative 
humidity level, post-conditioning weights can be used to generally understand the 
materials water retention capabilities.  Since Tyvek® is manufactured from 100% 
HDPE, it was not expected to respond significantly to changes in relative 
humidity.  In studying Figures 28 and 30, neither the Tyvek® 1073B nor the 
coated Tyvek® 1073B CR27 showed any consistent response to RH levels.  This 
is confirmed by Figures 29 and 31, which show the average moisture change and 
standard deviations with respect to relative humidity levels.  It is, however, 
interesting to see that although the responses to RH levels are inconsistent, both 
the coated and uncoated structures do show moisture gains and losses.  This 
was an unexpected phenomenon that warrants further research.  It is possible 
that the observed moisture variation is attributed to the variation in densities 
throughout the Tyvek® structure.  However in this experiment, samples were not 
individually marked; making it impossible for this data to determine the densities 
relevance to moisture gains or losses within Tyvek® 1073B coated and 
uncoated. 
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Figure 28:  Moisture gain/loss-Tyvek® 1073B uncoated 
 
 
Figure 29:  Average moisture gain/loss with standard deviations-Tyvek® 1073B uncoated 
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Figure 30:  Moisture gain/loss- Tyvek® 1073B coated 
 
 
Figure 31:  Average moisture gain/loss with standard deviations-Tyvek® 1073B coated 
 
As expected, the materials containing cellulose fibers, Ovantex and 55# 
Paper, demonstrated fairly consistent responses at each of the tested relative 
humidity levels.  The change in consistency, with respect to moisture, change at 
various relative humidity levels, from the Tyvek® 1073B structures, Figures 28-
31, and the Ovantex® and medical-grade paper, Figures 32-35, can most likely 
be attributed to the presence and prominence of cellulose fibers in both the 
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Ovantex® and medical-grade paper structures.  These cellulose fibers are more 
likely, than HDPE, to absorb/desorb the moisture in the RH chambers, which 
allows the materials to show more consistent responses to the change in RH 
levels. 
 
Figure 32:  Moisture gain/loss- dot coated Ovantex 
 
 
Figure 33:  Average moisture gain/loss with standard deviations-Ovantex® 
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Figure 34:  Moisture gain/loss- coated medical-grade paper 
 
 
Figure 35:  Average moisture gain/loss with standard deviations-medical-grade paper 
 
Microbial Penetration Test Results 
The average percent penetration through each material was plotted in 
Excel and analyzed.  Figures 38 and 39 show distinct microbial penetration vs. 
RH level curves with values varying as RH levels changed.  These observations 
led to the expectation that RH levels did significantly effect the microbial 
penetration for both the dot coated Ovantex and the coated 55# paper materials.  
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Figures 36 and 37 for the 1073B and coated 1073B CR27, respectively, 
demonstrated much variability in the microbial penetration data at very low 
penetration percentages and at all RH levels, which led to a hypothesis that 
neither the coated nor uncoated Tyvek® 1073B’s microbial penetration rate was 
significantly dependent on RH levels.  Although the results show in Figures 36 
and 37 demonstrate a statistical difference, at the penetration percentages 
observed; the results do not show a practical significant difference.  Variations 
shown by these graphs represent actual particle penetration variations of 
approximately ± 2 – 10 particles. 
 
Figure 36:  Average percent microbial penetration- Tyvek® 1073B uncoated 
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Figure 37:  Average percent microbial penetration- Tyvek® 1073B coated 
 
 
Figure 38:  Average percent microbial penetration- dot coated Ovantex 
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Figure 39:  Average percent microbial penetration- coated medical-grade paper 
 
Using Statistical Analysis Software (SAS) to perform a General Linear 
Model (GLM), these hypotheses were tested for statistical significance.  In an 
effort to achieve a high degree of confidence in the test results, a statistical 
significance was selected as a p-value of 0.05.  This means that, using a GLM, if 
the p-value is less than or equal to 0.05, then 95% of the time a correlation exists 
between the two variables being tested.  “The GLM statistical procedure uses the 
method of least squares to fit general linear models (SAS website).”   
The GLM analysis concluded, with a p-value greater than 0.05, that for 
each material, that the flow rate through the sample and relative humidity levels, 
affect the material’s microbial penetration rates independently of one another, 
Table 7.  This means that the two dynamic variables of the test, flow rate and RH 
level, are independent of one another.  Since they are independent, further 
analysis can be done to test both variables for their relationship to the microbial 
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penetration properties.  If these variables had been found dependent on one 
another, it would be impossible to determine whether flow rate or RH levels 
affected the microbial penetration properties of the sample.   
Using the same GLM analysis techniques, a study was performed with 
respect to the two dynamic test variables and microbial penetration properties.  
Table 7 demonstrates the conclusion that the flow rate across the sample was 
only found to be significant, p=<0.0001, for the medical-grade paper and 
Ovantex.  Relative humidity was found to have a significant effect, p=0.0016, on 
the microbial penetration properties for medical-grade paper.   
Table 7:  SAS generated p-values 
  P-value P-value P-value 
  flow rate and RH vs. flow rate vs.  RH vs. 
  
microbial 
penetration 
microbial 
penetration 
microbial 
penetration 
1073B 0.8929 0.0948 0.4743 
1073B CR27 0.4574 0.4265 0.3817 
55# Paper 0.1068 <0.0001 0.0016 
Ovantex 0.2498 <0.0001 0.3268 
Discussion 
Flow rate results found in the medical-grade paper and the Ovantex were 
expected as earlier research has observed similar occurrences (“A Discriminating 
Method”, 241).  This earlier research indicates a significance (p=0.05) of flow rate 
on microbial penetration for several materials.  The current research shows a 
significance, p=0.10, between the flow rate and particle penetration for the 
uncoated Tyvek® 1073B.  Further research would be necessary to determine 
whether it was the differences in test methods or the known structural variations 
in Tyvek® that caused the slight change in confidence for the flow rate and 
microbial barrier relationship.   
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It is recommended that future research characterizes the structural 
densities and porosities for individual Tyvek® samples.  This characterization will 
make it possible to determine if observed inconsistencies or statistically 
insignificant findings are due to actual test parameters or variations in the 
materials’ structure. 
Since little research has been published on the effects of coating on 
Tyvek®, the findings of this research are interesting.  This research suggests that 
the addition of Perfecseal’s CR27 coating to Tyvek® 1073B significantly 
decreases the impact flow rate has with respect to microbial penetration.  Future 
research examining various coatings with respect to their impact on microbial 
penetration and their impact on properties strongly related to microbial 
penetration (i.e. flow rate) could prove to be very beneficial research.  
Additionally, research using antimicrobial coatings, such as chitosan coatings, 
could aid porous materials with microbial barrier properties. 
Because the cellulose fibers that form paper are susceptible to moisture, it 
was not surprising to find that relative humidity had a significant effect with 
regards to the microbial penetration thru medical-grade paper.  It was interesting 
that the Ovantex, which also contains cellulose fibers, showed no significant 
relationship between microbial penetration and RH levels.   
Since the exact makeup of Ovantex is unknown, it is impractical to make 
suggestions with regards to the effect of cellulose fibers and RH have on 
microbial barrier properties, however much research can be performed in this 
area.  It would be interesting to determine what types of fibers are most 
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susceptible to changes in RH levels, and what percentage of cellulose fibers in a 
material structure compromise its microbial barrier properties.  It would also be 
interesting to research how materials containing cellulose fibers react to 
microbes over time.  Could microbes with a food source (cellulose fibers and 
water) eventually penetrate a package by “eating through” the material?   
Conclusion 
 Relative humidity levels have a significant effect on the particle 
penetration levels for the medical-grade paper tested, 55 pound latex 
impregnated paper coated with Perfecseal’s CR27 coating.  Manufacturers 
planning to package using medical-grade paper should be concerned with the 
distribution and storage relative humidity levels for their products, because as 
previously stated, ISO 11607 requires manufacturers to ensure the sterility of 
their product from production until point-of-use.   
 Relative humidity levels do not appear to have any effect on the particle 
penetration levels for the dot coated Ovantex, by Oliver® Medical, or the coated 
and uncoated 1073B Tyvek®, by DuPont.   
Table 8:  Summary of conclusions 
Material Tested Does flow rate effect 
microbial penetration? 
(95% confidence) 
Does RH level effect 
microbial penetration?  
(95% confidence) 
Tyvek® 1073B No No 
coated Tyvek® 1073B No No 
dot coated Ovantex Yes No 
coated 55# medical-
grade paper Yes Yes 
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APPENDIX A:  Pmax Curves 
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APPENDIX B:  Data filtering technique 
 
1. Raw Data- filtered for example test run time 
Dat
e Time 
Filtr
ate 
0.7 
Filtr
ate 
1.0 
Filtr
ate 
(0.7
+1.
0) 
Chall
enge 
0.7 
Chall
enge 
1.0 
Cha
llen
ge 
(0.7
+1.0
) 
Sample 
dP (in 
H2O) 
Vent 
Prsr (in 
H2O) 
Vac Gen 
Prsr 
(psig) 
Atomizer 
Prsr 
(psig) 
Atomizer 
1 Flow 
(lpm) 
Atomizer 
2 Flow 
(lpm) 
Filtr
ate 
all 
Chall
enge 
all 
filtrate 
flow 
(lpm) 
4/20
/200
9 
11:03
:00 
AM 12 3 15 8326 1515 
984
1 0.065 0.873 1.8 31.2 1.36 2.02 238 
4209
9 0.06 
4/20
/200
9 
11:03
:06 
AM 17 6 23 8305 1579 
988
4 0.065 0.866 1.8 31.2 1.33 2.02 273 
4233
4 0.06 
4/20
/200
9 
11:03
:12 
AM 10 2 12 8408 1599 
100
07 0.065 0.864 1.8 31.2 1.33 2.02 272 
4187
9 0.06 
4/20
/200
9 
11:03
:18 
AM 5 3 8 8470 1589 
100
59 0.065 0.863 1.8 31.2 1.33 2.02 249 
4265
3 0.06 
4/20
/200
9 
11:03
:24 
AM 7 0 7 8415 1535 
995
0 0.065 0.862 1.8 31.2 1.33 2.02 276 
4277
6 0.06 
4/20
/200
9 
11:03
:30 
AM 7 1 8 8482 1581 
100
63 0.065 0.863 1.8 31.2 1.33 2.02 257 
4279
7 0.06 
4/20
/200
9 
11:03
:36 
AM 6 0 6 8597 1647 
102
44 0.065 0.862 1.8 31.2 1.33 2.02 216 
4288
0 0.06 
4/20
/200
9 
11:03
:42 
AM 8 0 8 8640 1615 
102
55 0.065 0.862 1.8 31.2 1.33 2.02 253 
4364
8 0.06 
4/20
/200
9 
11:03
:48 
AM 8 1 9 8758 1652 
104
10 0.065 0.862 1.8 31.2 1.33 2.02 243 
4343
0 0.06 
4/20
/200
9 
11:03
:54 
AM 7 4 11 8558 1529 
100
87 0.065 0.863 1.8 31.2 1.33 2.02 233 
4299
5 0.06 
4/20
/200
9 
11:04
:00 
AM 6 0 6 8748 1643 
103
91 0.065 0.863 1.8 31.2 1.33 2.02 230 
4276
9 0.06 
 
2. Data filtered for needed information- date, time, filtered particles 0.7  and 
1.0 µm in diameter, challenge particles 0.7  and 1.0 µm in diameter, filtrate 
flow through sample. 
Date Time Filtrate(0.7+1.0) Challenge(0.7+1.0) filtrate flow (lpm) 
4/20/2009 11:03:00 AM 15 9841 0.06 
4/20/2009 11:03:06 AM 23 9884 0.06 
4/20/2009 11:03:12 AM 12 10007 0.06 
4/20/2009 11:03:18 AM 8 10059 0.06 
4/20/2009 11:03:24 AM 7 9950 0.06 
4/20/2009 11:03:30 AM 8 10063 0.06 
4/20/2009 11:03:36 AM 6 10244 0.06 
4/20/2009 11:03:42 AM 8 10255 0.06 
4/20/2009 11:03:48 AM 9 10410 0.06 
4/20/2009 11:03:54 AM 11 10087 0.06 
4/20/2009 11:04:00 AM 6 10391 0.06 
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3. A query was run (using MS Access) to link the appropriate time with the 
material sample and RH level tested. 
Date Time Sample ID 
Material 
ID 
RH 
% 
filtrate 
flow (lpm) 
Challenge 
(0.7+1.0) 
Filtrate 
(0.7+1.0) 
4/20/2009 11:03:00 AM B-90-6 B 90 0.06 9841 15 
4/20/2009 11:03:06 AM B-90-6 B 90 0.06 9884 23 
4/20/2009 11:03:12 AM B-90-6 B 90 0.06 10007 12 
4/20/2009 11:03:18 AM B-90-6 B 90 0.06 10059 8 
4/20/2009 11:03:24 AM B-90-6 B 90 0.06 9950 7 
4/20/2009 11:03:30 AM B-90-6 B 90 0.06 10063 8 
4/20/2009 11:03:36 AM B-90-6 B 90 0.06 10244 6 
4/20/2009 11:03:42 AM B-90-6 B 90 0.06 10255 8 
4/20/2009 11:03:48 AM B-90-6 B 90 0.06 10410 9 
4/20/2009 11:03:54 AM B-90-6 B 90 0.06 10087 11 
4/20/2009 11:04:00 AM B-90-6 B 90 0.06 10391 6 
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4. Penetration percentages were then calculated, Penrate=(challenge-
filtrate/challenge).   
Date Time Sample ID 
Material 
ID 
RH 
%
filtrate 
flow 
(lpm)
Challeng
e
(0#7+1#0
)
Filtrate 
(0#7+1#0
) 
penrate
4/20/2009 11:03:00 AM 
B-90-
6 B 90 0.06 9841 15 
0.00152423
5
4/20/2009 11:03:06 AM 
B-90-
6 B 90 0.06 9884 23 
0.00232699
3
4/20/2009 11:03:12 AM 
B-90-
6 B 90 0.06 10007 12 
0.00119916
1
4/20/2009 11:03:18 AM 
B-90-
6 B 90 0.06 10059 8 
0.00079530
8
4/20/2009 11:03:24 AM 
B-90-
6 B 90 0.06 9950 7 
0.00070351
8
4/20/2009 11:03:30 AM 
B-90-
6 B 90 0.06 10063 8 
0.00079499
2
4/20/2009 11:03:36 AM 
B-90-
6 B 90 0.06 10244 6 
0.00058570
9
4/20/2009 11:03:42 AM 
B-90-
6 B 90 0.06 10255 8 
0.00078010
7
4/20/2009 11:03:48 AM 
B-90-
6 B 90 0.06 10410 9 
0.00086455
3
4/20/2009 11:03:54 AM 
B-90-
6 B 90 0.06 10087 11 
0.00109051
3
4/20/2009 11:04:00 AM 
B-90-
6 B 90 0.06 10391 6 
0.00057742
3
 
5. Averages were taken for the one minute time period for each sample 
(example shown for B-90-6 sample or 1073B with 90% RH at 0.06 lpm 
flow rate). 
 
 Challenge Filtrate 
% 
Penetration
90 10452.91 5.333333 0.05%
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